Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs
Summary
Dozens of UK MPs oppose Health Secretary Wes Streeting’s new power to tell the NHS what to pay for drugs, worrying this move may be illegal and will weaken an independent body called NICE that sets fair drug prices. The change comes from a UK-US drug pricing deal linked to President Donald Trump’s administration, which critics say will cost the NHS more and benefit drug companies.Key Facts
- Wes Streeting gained power to overrule NICE’s drug pricing decisions for the NHS.
- Thirty-one MPs signed a motion opposing this new power.
- NICE has set drug prices since 1999 to ensure value for NHS spending.
- Critics say the change threatens NICE’s independence and patient care.
- The UK-US deal allows UK drug exports to the US to avoid tariffs.
- Andrew Lansley, a former Conservative health secretary, also opposes the regulations.
- Health experts warn higher drug costs will force NHS cuts to other services.
- The deal is linked to pressure from President Donald Trump’s administration.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.